Satoaki Matoba

18.6k total citations · 2 hit papers
321 papers, 6.9k citations indexed

About

Satoaki Matoba is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Satoaki Matoba has authored 321 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Cardiology and Cardiovascular Medicine, 99 papers in Surgery and 82 papers in Molecular Biology. Recurrent topics in Satoaki Matoba's work include Cardiac Valve Diseases and Treatments (38 papers), Peripheral Artery Disease Management (33 papers) and Cardiovascular Function and Risk Factors (31 papers). Satoaki Matoba is often cited by papers focused on Cardiac Valve Diseases and Treatments (38 papers), Peripheral Artery Disease Management (33 papers) and Cardiovascular Function and Risk Factors (31 papers). Satoaki Matoba collaborates with scholars based in Japan, United States and Germany. Satoaki Matoba's co-authors include Paul M. Hwang, Koji Ikeda, Ju‐Gyeong Kang, Willmar D. Patino, Andrew Wragg, Paula J. Hurley, Oksana Gavrilova, Manfred Boehm, Fred Bunz and Atsushi Hoshino and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Satoaki Matoba

286 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53 Regulates Mitochondrial Respiration

2006 1.3k citations Satoaki Matoba, Ju‐Gyeong Kang et al. Science profile →
Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart

2013 443 citations Atsushi Hoshino, Tomomi Ueyama et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoaki Matoba Japan	41	3.4k	1.6k	1.2k	1.1k	1.0k	321	6.9k
Suresh C. Tyagi United States	52	2.7k 0.8×	1.3k 0.8×	947 0.8×	896 0.8×	763 0.8×	192	8.2k
Yoshiji Yamada Japan	46	3.6k 1.0×	1.4k 0.9×	792 0.7×	1.1k 1.0×	692 0.7×	220	7.6k
Frank C. Brosius United States	54	4.1k 1.2×	1.6k 1.0×	744 0.6×	1.5k 1.3×	680 0.7×	146	9.6k
Wayne Bond Lau United States	46	2.6k 0.8×	1.7k 1.1×	852 0.7×	655 0.6×	1.7k 1.7×	130	6.0k
Bodo Levkau Germany	52	4.8k 1.4×	1.8k 1.2×	1.2k 1.0×	2.0k 1.8×	553 0.5×	157	9.2k
Hossein Ardehali United States	43	3.4k 1.0×	1.8k 1.1×	1.1k 0.9×	608 0.6×	475 0.5×	109	6.9k
Shigehiro Katayama Japan	45	2.7k 0.8×	1.8k 1.2×	592 0.5×	1.2k 1.1×	776 0.8×	224	8.2k
Teresa Padró Spain	43	2.9k 0.8×	1.8k 1.1×	1.3k 1.1×	1.5k 1.4×	597 0.6×	197	7.2k
Giovanni G. Camici Switzerland	47	2.7k 0.8×	1.6k 1.0×	564 0.5×	861 0.8×	823 0.8×	214	7.2k
Zamaneh Kassiri Canada	48	2.4k 0.7×	3.1k 1.9×	1.3k 1.1×	1.3k 1.2×	489 0.5×	105	7.3k

Countries citing papers authored by Satoaki Matoba

Since Specialization

Citations

This map shows the geographic impact of Satoaki Matoba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoaki Matoba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoaki Matoba more than expected).

Fields of papers citing papers by Satoaki Matoba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoaki Matoba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoaki Matoba. The network helps show where Satoaki Matoba may publish in the future.

Co-authorship network of co-authors of Satoaki Matoba

This figure shows the co-authorship network connecting the top 25 collaborators of Satoaki Matoba. A scholar is included among the top collaborators of Satoaki Matoba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoaki Matoba. Satoaki Matoba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gojo, Satoshi, et al.. (2025). Sephin1 suppresses ER stress-induced cell death by inhibiting the formation of PP2A holoenzyme. Cell Death and Disease. 16(1). 117–117. 1 indexed citations

Ito, Takaaki, Yusuke Sakai, Keisuke Nishioka, et al.. (2025). Engineered ACE2 decoy in dry powder form for inhalation: A novel therapy for SARS-CoV-2 variants. Molecular Therapy — Methods & Clinical Development. 33(2). 101459–101459. 1 indexed citations

Ogata, Takehiro, et al.. (2024). Myofibroblasts impair myocardial impulse propagation by heterocellular connexin43 gap-junctional coupling through micropores. Frontiers in Physiology. 15. 1352911–1352911. 4 indexed citations

Fukai, Kuniyoshi, Yoshihiro Iwasaki, Keita Hirano, et al.. (2024). Predictors of recurrent restenosis after repeat drug‐coated balloon therapy for drug‐coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study. Catheterization and Cardiovascular Interventions. 104(6). 1241–1250.

Ito, Nobuyasu, Kan Zen, Shunsuke Nakamura, et al.. (2023). Left Ventricular Hypertrophy as a Predictor of Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement. ESC Heart Failure. 10(2). 1336–1346. 5 indexed citations

Zen, Kan, et al.. (2023). Optical coherence tomography finding for restenosis in the superficial femoral artery treated with paclitaxel-coated balloon. Cardiovascular Intervention and Therapeutics. 39(1). 93–94. 2 indexed citations

Inoue, Ken, Kan Zen, Reo Kobayashi, et al.. (2023). Gastrointestinal Angiodysplasia in Patients with Severe Aortic Stenosis: The Endoscopic Features of Heyde’s Syndrome. Digestion. 104(6). 468–479. 2 indexed citations

Imai, Kojiro, Isao Yokota, Kei Fujikawa, et al.. (2023). A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans. Circulation Journal. 87(9). 1229–1237. 5 indexed citations

Kawasaki, Tatsuya, Hirokazu Shiraishi, & Satoaki Matoba. (2023). Clinical Significance of Physical Examination for Hypertrophic Cardiomyopathy. Circulation Journal. 87(8). 1068–1074. 1 indexed citations

10.

Matoba, Satoaki, et al.. (2022). Abstract 12397: A First Case of Myocardial Infarction Due to Multisystem Inflammatory Syndrome After Sars-cov-2 Vaccination. Circulation. 146(Suppl_1).

11.

Nishi, Takeshi, Masanobu Ishii, Kenichi Tsujita, et al.. (2022). Outcomes of Venoarterial Extracorporeal Membrane Oxygenation Plus Intra‐Aortic Balloon Pumping for Treatment of Acute Myocardial Infarction Complicated by Cardiogenic Shock. Journal of the American Heart Association. 11(7). e023713–e023713. 30 indexed citations

12.

Zen, Kan, et al.. (2022). Additional balloon aortic valvuloplasty to overcome the difficult removal of a self‐expandable transcatheter aortic valve system due to valve infolding. Catheterization and Cardiovascular Interventions. 100(7). 1331–1335. 1 indexed citations

13.

Higuchi, Yusuke, Tatsuya Suzuki, Takao Arimori, et al.. (2021). Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2. Nature Communications. 12(1). 3802–3802. 76 indexed citations

14.

Maeda, Hideki, Daisuke Kami, Yuki Murata, et al.. (2020). TAT‐dextran–mediated mitochondrial transfer enhances recovery from models of reperfusion injury in cultured cardiomyocytes. Journal of Cellular and Molecular Medicine. 24(9). 5007–5020. 47 indexed citations

15.

Shiraishi, Hirokazu, et al.. (2020). A case of cardiac tamponade due to coronary artery injury caused by atrial screw-in lead. Journal of Cardiology Cases. 23(2). 80–82. 3 indexed citations

16.

Nakanishi, Nobuhiro, et al.. (2019). A Case of Acute Renal Failure with Hemolysis Caused by Impella. Clinical Case Reports. 9(6). 1–4. 1 indexed citations

17.

Kadoya, Yoshito, et al.. (2018). Rail‐tracking calcification of lower limb arteries. Clinical Case Reports. 6(9). 1921–1922. 3 indexed citations

18.

Akakabe, Yoshiki, Masahiro Koide, Yohei Kitamura, et al.. (2013). Ecscr regulates insulin sensitivity and predisposition to obesity by modulating endothelial cell functions. Nature Communications. 4(1). 2389–2389. 24 indexed citations

19.

Noto, Yu‐ichi, Takahiko Tokuda, Kensuke Shiga, et al.. (2009). Cardiomyopathy in a Japanese family with the Glu61Lys transthyretin variant: a new phenotype. Amyloid. 16(2). 99–102. 6 indexed citations

20.

Matoba, Satoaki, Ju‐Gyeong Kang, Willmar D. Patino, et al.. (2006). p53 Regulates Mitochondrial Respiration. Science. 312(5780). 1650–1653. 1327 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact